[Clopidogrel--an expensive thrombocyte inhibitor with a small marginal benefit].
Asplund
K
K
Medicinska kliniken, Norrlands Universitetssjukhus, Umeå.
D001241:Aspirin / Q000191:economics / Q000627:therapeutic use; D000077144:Clopidogrel; D003327:Coronary Disease / Q000188:drug therapy; D003362:Cost-Benefit Analysis; D006801:Humans; D017202:Myocardial Ischemia / Q000188:drug therapy* / Q000191:economics / Q000517:prevention & control; D010975:Platelet Aggregation Inhibitors / Q000191:economics* / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin